Clinical Trial Update: Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. [Phase 2]

View source ↗

Summary

Clinical trial evaluating dose-escalated, hypofractionated definitive proton radiotherapy for patients with inoperable soft tissue sarcoma (Phase 2, recruiting)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma
• Myxofibrosarcoma
• Pleomorphic Liposarcoma
• Pleomorphic Rhabdomyosarcoma
• Soft Tissue Sarcoma
• Synovial Sarcoma
• Undifferentiated Pleomorphic Sarcoma

Snippet

Sponsor: Oslo University Hospital | Conditions: Soft Tissue Sarcoma (STS), Soft Tissue Sarcoma Adult | Phase 2 | Status: RECRUITING